<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 2 Issue 1</issue_number>
<issue_period>2011 (January - March) </issue_period>
<title>DIFFERENTIAL EFFECT OF ANTIDEPRESSANTS ON Gqα -PROTEIN LEVELS IN RAT BRAIN</title>
<abstract>Heterotrimeric G proteins play a pivotal role in post receptor information transduction. These proteins have been implicated in the pathophysiology, diagnosis, and treatment of depression. Aims and Objectives: The aim of the present study was to examine the effect of chronic antidepressants treatment on the Gqα-protein levels in rat brain. Density of Gqα/11α-protein levels was measured in cortex and cerebellum of rats treated with amitriptyline (AMI), desipramine (DMI) and fluoxetine (FLX) and imipramine (10 mg/Kg body wt), for 30 days, using Sodium Dodecyl Sulphate – Polyacrylamide Gel Electrophoresis (SDS-PAGE) and western blotting. In cortex, a significant decrease was observed after AMI treatment (28%, p lessThan  0.0001), followed by DMI (17%, p lessThan  0.0001) and CMI (19%, p lessThan  0.0001). In contrast a significant increase was observed after IMI treatment (14%, p lessThan  0.001) but there was no change in fluoxetine treatment. In cerebellum, a significant increase in Gqprotein levels was observed after treatment with all the above drugs. A very high increase was observed after CMI treatment (114%, p lessThan  0.0001) as compared to AMI (59%, p lessThan  0.0001), DMI (45%, p lessThan  0.0001) fluoxetine (28%, p lessThan  0.0001) and IMI (42%, p lessThan  0.0001). The results suggest that chronic antidepressant (AD) treatment decreases the expression of cortical Gqα/11α-protein levels in contrast to cerebellum where these proteins are showed increased expression. However IMI treatment in cortical Gqα/11αprotein levels predominantly over expressed by IMI treatment. The region-specific expression of Gqα/11α-protein levels which occurs after prolonged AD treatment, may underline the therapeutic mechanism of action.  lessThan br / greaterThan  </abstract>
<authors>RAMAKRISHNA D,SUMEET ROY,G.C.REDDY,SUBHASH,M.N.</authors>
<keywords>G-proteins, Antidepressants, SDS-PAGE, Western blotting </keywords>
<pages>348-355</pages>
</article>
</Journal>
